Human myometrium and leiomyomas express gonadotropin-releasing hormone 2 and gonadotropin-releasing hormone 2 receptor

Fertility and Sterility

Volumn 88, Issue 1, 2007, Pages 39-46

  Parker, Jason D ^a,b,c   Malik, Minnie ^c   Catherino, William H ^a,b,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

GnRH2 and GnRHR2; immunohistochemistry; microarray analysis; real time RT PCR; RT PCR; Western blot

Indexed keywords

GONADORELIN DERIVATIVE; GONADORELIN RECEPTOR; GONADOTROPIN RELEASING HORMONE 2; GONADOTROPIN RELEASING HORMONE 2 RECEPTOR; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOCRINE EFFECT; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; MICROARRAY ANALYSIS; MYOMETRIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNIVERSITY HOSPITAL;

ADULT; FEMALE; GENE EXPRESSION REGULATION; GONADOTROPIN-RELEASING HORMONE; HUMANS; LEIOMYOMA; MIDDLE AGED; MYOMETRIUM; PROTEIN ISOFORMS; RECEPTORS, LHRH;

EID: 34347330327     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.11.098     Document Type: Article

References (51)

1. Cramer D.W. Epidemiology of myomas. Semin Reprod Endocrinol 10 (1992) 320-334
2. Buttram V., and Reiter R. Uterine leiomyomata: etiology, symptomatology and management. Fertil Steril 36 (1981) 433-445
3. Cramer S.F., and Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 94 (1990) 435-438
4. Fedele L., Parazzini F., Luchini L., Mezzopane R., Tozzi L., and Villa L. Recurrence of fibroids after myomectomy: a transvaginal ultrasonographic study. Hum Reprod 10 (1995) 1795-1796
5. Fauconnier A., Chapron C., Babaki-Fard K., and Dubuisson J.B. Recurrence of leiomyomata after myomectomy. Hum Reprod Update 6 (2000) 595-602
6. Iverson Jr. R.E., Chelmow D., Strohbehn K., Waldman L., and Evantash E.G. Relative morbidity of abdominal hysterectomy and myomectomy for management of uterine leiomyomas. Obstet Gynecol 88 (1996) 415-419
7. Robboy S.J., Bentley R.C., Butnor K., and Anderson M.C. Pathology and pathophysiology of uterine smooth-muscle tumors. Environ Health Perspect 108 (2000) 779-784
8. Stewart E.A. Uterine fibroids. Lancet 357 (2001) 293-298
9. Felberbaum R.E., Kupker W., Krapp M., Gehl B., Ludwig M., and Diedrich K. Preoperative reduction of uterine fibroids in only 16 days by administration of a gonadotrophin-releasing hormone antagonist (Cetrotide). Reprod Biomed Online 3 (2001) 14-18
10. Vollenhoven B.J., Shekleton P., McDonald J., and Healy D.L. Clinical predictors for buserelin acetate treatment of uterine fibroids: a prospective study of 40 women. Fertil Steril 54 (1990) 1032-1038
11. Azad N., LaPaglia N., Kirsteins L., Uddin S., Steiner J., Williams D.W., et al. Jurkat cell proliferative activity is increased by luteinizing hormone-releasing hormone. J Endocrinol 153 (1997) 241-249
12. Chen H.F., Jeung E.B., Stephenson M., and Leung P.C. Human peripheral blood mononuclear cells express gonadotropin-releasing hormone (GnRH), GnRH receptor, and interleukin-2 receptor gamma-chain messenger ribonucleic acids that are regulated by GnRH in vitro. J Clin Endocrinol Metab 84 (1999) 743-750
13. Chen A., Ganor Y., Rahimipour S., Ben-Aroya N., Koch Y., and Levite M. The neuropeptides GnRH-II and GnRH-I are produced by human T cells and trigger laminin receptor gene expression, adhesion, chemotaxis and homing to specific organs. Nat Med 8 (2002) 1421-1426
14. Chen A., Kaganovsky E., Rahimipour S., Ben-Aroya N., Okon E., and Koch Y. Two forms of gonadotropin-releasing hormone (GnRH) are expressed in human breast tissue and overexpressed in breast cancer: a putative mechanism for the antiproliferative effect of GnRH by down-regulation of acidic ribosomal phosphoproteins P1 and P2. Cancer Res 62 (2002) 1036-1044
15. Harris N., Dutlow C., Eidne K., Dong K.W., Roberts J., and Millar R. Gonadotropin-releasing hormone gene expression in MDA-MB-231 and ZR-75-1 breast carcinoma cell lines. Cancer Res 51 (1991) 2577-2581
16. Chou C.S., Beristain A.G., MacCalman C.D., and Leung P.C. Cellular localization of gonadotropin-releasing hormone (GnRH) I and GnRH II in first-trimester human placenta and decidua. J Clin Endocrinol Metab 89 (2004) 1459-1466
17. Kang S.K., Choi K.C., Cheng K.W., Nathwani P.S., Auersperg N., and Leung P.C. Role of gonadotropin-releasing hormone as an autocrine growth factor in human ovarian surface epithelium. Endocrinology 141 (2000) 72-80
18. Raga F., Casan E.M., Kruessel J.S., Wen Y., Huang H.Y., Nezhat C., et al. Quantitative gonadotropin-releasing hormone gene expression and immunohistochemical localization in human endometrium throughout the menstrual cycle. Biol Reprod 59 (1998) 661-669
19. Dong K.W., Marcelin K., Hsu M.I., Chiang C.M., Hoffman G., and Roberts J.L. Expression of gonadotropin-releasing hormone (GnRH) gene in human uterine endometrial tissue. Mol Hum Reprod 4 (1998) 893-898
20. Chegini N., Rong H., Dou Q., Kipersztok S., and Williams R.S. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro. J Clin Endocrinol Metab 81 (1996) 3215-3221
21. Kobayashi Y., Zhai Y.L., Iinuma M., Horiuchi A., Nikaido T., and Fujii S. Effects of a GnRH analogue on human smooth muscle cells cultured from normal myometrial and from uterine leiomyomal tissues. Mol Hum Reprod 3 (1997) 91-99
22. Grundker C., Gunthert A.R., Millar R.P., and Emons G. Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. J Clin Endocrinol Metab 87 (2002) 1427-1430
23. Irmer G., Burger C., Ortmann O., Schulz K.D., and Emons G. Expression of luteinizing hormone releasing hormone and its mRNA in human endometrial cancer cell lines. J Clin Endocrinol Metab 79 (1994) 916-919
24. Chatzaki E., Bax C.M., Eidne K.A., Anderson L., Grudzinskas J.G., and Gallagher C.J. The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth factor. Cancer Res 56 (1996) 2059-2065
25. White R.B., Eisen J.A., Kasten T.L., and Fernald R.D. Second gene for gonadotropin-releasing hormone in humans. Proc Natl Acad Sci USA 95 (1998) 305-309
26. Miyamoto K., Hasegawa Y., Nomura M., Igarashi M., Kangawa K., and Matsuo H. Identification of the second gonadotropin-releasing hormone in chicken hypothalamus: evidence that gonadotropin secretion is probably controlled by two distinct gonadotropin-releasing hormone in avian species. Proc Natl Acad Sci USA 81 (1984) 3874-3878
27. Cheon K.W., Lee H.S., Parhar I.S., and Kang I.S. Expression of the second isoform of gonadotrophin-releasing hormone (GnRH-II) in human endometrium throughout the menstrual cycle. Mol Hum Reprod 7 (2001) 447-452
28. Grundker C., and Emmons G. Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer. Reprod Biol Endocrinol 1 (2003) 65-72
29. Catherino W.H., Prupas C., Tsibris J.C., Leppert P.C., Payson M., Nieman L.K., et al. Strategy for elucidating differentially expressed genes in leiomyomata identified by microarray technology. Fertil Steril 80 (2003) 282-290
30. Catherino W.H., Leppert P.C., Stenmark M.H., Payson M., Potlog-Nahari C., Nieman L.K., et al. Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes Chrom Cancer 40 (2004) 204-217
31. Lipshutz R.J., Fodor S.P., Gingeras T.R., and Lockhart D.J. High density synthetic oligonucleotide arrays. Nat Genet 21 (1999) 20-24
32. Chen A., Yahalom D., Ben-Aroya N., Kaganovsky E., Okon E., and Koch Y. A second isoform of gonadotropin-releasing hormone is present in the brain of human and rodents. FEBS Lett 435 (1998) 199-203
33. Okuzawa K., Amano M., Kobayashi M., Aida K., Hanyu I., Hasegawa Y., et al. Differences in salmon GnRH and chicken GnRH-II contents in discrete brain areas of male and female rainbow trout according to age and stage of maturity. Gen Comp Endocrinol 80 (1990) 116-126
34. Gestrin E.D., White R.B., and Fernald R.D. Second form of gonadotropin-releasing hormone in mouse: immunocytochemistry reveals hippocampal and periventricular distribution. FEBS Lett 448 (1999) 289-291
35. Parhar I.S., Soga T., Ogawa S., Ogawa S., Pfaff D.W., and Sakuma Y. Nonmammalian gonadotropin-releasing hormone molecules in the brain of promoter transgenic rats. Proc Natl Acad Sci 102 (2005) 5880-5885
36. Chen A., Yahalom D., Laskar-Levy O., Rahimipour S., Ben-Aroya N., and Koch Y. Two isoforms of gonadotropin-releasing hormone are coexpressed in neuronal cell lines. Endocrinology 142 (2001) 830-837
37. Grundker C., Gunthert A.R., Westphalen S., and Emons G. Biology of the GnRH system in human gynecological cancers. Eur J Endocrinol 146 (2002) 1-14
38. Schally A.V. LH-RH analogues: their impact on human reproduction and the control of tumorigenesis. Peptides 20 (1999) 1247-1262
39. Emons G., and Schally A.V. The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers. Hum Reprod 9 (1994) 1364-1379
40. Emons G., Ortmann O., Schulz K.D., and Schally A.V. Growth inhibitory actions of analogues of luteinizing hormone releasing hormone on tumour cells. Trends Endocrinol Metab 8 (1997) 355-362
41. Miller W.R., Scott W.N., Morris R., Fraser H.M., and Sharpe R.M. Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist. Nature 313 (1985) 231-233
42. Batticane N., Morale M.C., Gallo F., Farinella Z., and Marchetti B. Luteinizing hormone-releasing hormone signaling at the lymphocyte involves stimulation of interleukin-2 receptor expression. Endocrinology 129 (1991) 277-286
43. Marchetti B., Guarcello V., Morale M.C., Bartoloni G., Raiti F., Palumbo Jr. G., et al. Luteinizing hormone-releasing hormone (LHRH) agonist restoration of age-associated decline of thymus weight, thymic LHRH receptors, and thymocyte proliferative capacity. Endocrinology 125 (1989) 1037-1045
44. Friedman A.J., Harrison-Atlas D., Barbieri R.L., Benacerraf B., Gleason R., and Schiff I. A randomized, placebo controlled, double blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata. Fertil Steril 51 (1989) 251-256
45. Lumsden M.A., West C.P., and Baird D.T. Goserelin therapy before surgery for uterine fibroids. Lancet 1 (1987) 36-37
46. Matta W.H., Stabile I., Shaw R.W., and Campbell S. Doppler assessment of uterine blood flow changes in patients with fibroids receiving the GnRH agonist buserelin. Fertil Steril 49 (1988) 1083-1085
47. Chegini N., Verala J., Luo X., Xu J., and Williams R.S. Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. J Soc Gynecol Invest 10 (2003) 161-171
48. Xu J., Luo X., and Chegini N. Differential expression, regulation, and induction of Smads, transforming growth factor-beta signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog. J Clin Endocrinol Metab 88 (2003) 1350-1361
49. Ding L., Xu J., Luo X., and Chegini N. Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells. J Clin Endocrinol Metab 89 (2004) 5549-5557
50. Luo X., Ding L., Xu J., Williams R.S., and Chegini N. Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy. Endocrinology 146 (2005) 1074-1096
51. Kwon J.Y., Park K.H., Park Y.N., and Cho N.H. Effect of cetrorelix acetate on apoptosis and apoptosis regulatory factors in cultured uterine leiomyoma cells. Fertil Steril 84 (2005) 1526-1528